{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:24:56Z","timestamp":1787635496048,"version":"build-2736575974"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biopha.2025.118922","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:34:21Z","timestamp":1767681261000},"page":"118922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Contribution of the serotonergic system to myopia and the therapeutic effects of atropine and pirenzepine"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2272-2800","authenticated-orcid":false,"given":"Kate","family":"Thomson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Karouta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regan","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118922_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","article-title":"The epidemics of myopia: aetiology and prevention","volume":"62","author":"Morgan","year":"2018","journal-title":"Prog. Retin Eye Res"},{"issue":"3","key":"10.1016\/j.biopha.2025.118922_bib2","doi-asserted-by":"crossref","first-page":"M106","DOI":"10.1167\/iovs.18-25958","article-title":"IMI\u2013interventions for controlling myopia onset and progression report","volume":"60","author":"Wildsoet","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2025.118922_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/opo.12052","article-title":"How does atropine exert its anti-myopia effects?","volume":"33","author":"McBrien","year":"2013","journal-title":"Ophthal Physiol. Opt."},{"issue":"22","key":"10.1016\/j.biopha.2025.118922_bib4","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1111\/bph.15629","article-title":"Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release","volume":"178","author":"Thomson","year":"2021","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2025.118922_bib5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/cxo.12871","article-title":"Alpha(2) -adrenoceptor agonists inhibit form-deprivation myopia in the chick","volume":"102","author":"Carr","year":"2019","journal-title":"Clin. Exp. Optom."},{"issue":"5","key":"10.1016\/j.biopha.2025.118922_bib6","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.exer.2005.03.021","article-title":"Retinal serotonin, eye growth and myopia development in chick","volume":"81","author":"George","year":"2005","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118922_bib7","first-page":"557","article-title":"Effects of nicotinic antagonists on ocular growth and experimental myopia","volume":"42","author":"Stone","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2025.118922_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/iovs.65.11.29","article-title":"Administration of nicotine can inhibit myopic growth in animal models","volume":"65","author":"Thomson","year":"2024","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118922_bib9","doi-asserted-by":"crossref","first-page":"M31","DOI":"10.1167\/iovs.18-25967","article-title":"IMI - report on experimental models of emmetropization and myopia","volume":"60","author":"Troilo","year":"2019","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118922_bib10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1124\/mol.52.5.886","article-title":"Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects","volume":"52","author":"Zwart","year":"1997","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118922_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.bjp.0705124","article-title":"Interactions of atropine with heterologously expressed and native alpha 3 subunit-containing nicotinic acetylcholine receptors","volume":"138","author":"Parker","year":"2003","journal-title":"Br. J. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2025.118922_bib12","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1167\/iovs.17-22562","article-title":"Myopia-inhibiting concentrations of muscarinic receptor antagonists block activation of alpha2A-adrenoceptors in vitro","volume":"59","author":"Carr","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2025.118922_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuropharm.2016.04.027","article-title":"The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors","volume":"108","author":"Lochner","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118922_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115542","article-title":"The role of the serotonergic system in atropine's anti-myopic effects","volume":"167","author":"Thomson","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118922_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100779","article-title":"Light inhibits lens-induced myopia through an intensity-dependent dopaminergic mechanism","volume":"5","author":"Karouta","year":"2025","journal-title":"Ophthalmol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118922_bib16","article-title":"Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Du Sert","year":"2020","journal-title":"PLoS Biol."},{"issue":"4362","key":"10.1016\/j.biopha.2025.118922_bib17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1126\/science.694514","article-title":"Extreme myopia produced by modest change in early visual experience","volume":"201","author":"Wallman","year":"1978","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib18","doi-asserted-by":"crossref","first-page":"18345","DOI":"10.1038\/s41598-019-54789-5","article-title":"Effectiveness and safety of topical levodopa in a chick model of myopia","volume":"9","author":"Thomson","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib19","doi-asserted-by":"crossref","first-page":"13242","DOI":"10.1038\/s41598-020-70271-z","article-title":"Levodopa inhibits the development of lens-induced myopia in chicks","volume":"10","author":"Thomson","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1167\/iovs.14-15499","article-title":"Correlation between light levels and the development of deprivation myopia","volume":"56","author":"Karouta","year":"2014","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118922_bib21","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100350RR","article-title":"Transcriptome-based insights into gene networks controlling myopia prevention","volume":"35","author":"Karouta","year":"2021","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118922_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"D1","key":"10.1016\/j.biopha.2025.118922_bib23","doi-asserted-by":"crossref","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","article-title":"PubChem 2025 update","volume":"53","author":"Kim","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.biopha.2025.118922_bib24","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.66.12.52","article-title":"Methylphenidate inhibits the development of myopia by altering dopamine and norepinephrine reuptake","volume":"66","author":"Karouta","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj1080095","article-title":"The distribution of monoamine oxidase and alpha-glycerophosphate dehydrogenase in pig brain","volume":"108","author":"Tipton","year":"1968","journal-title":"Biochem J."},{"key":"10.1016\/j.biopha.2025.118922_bib26","first-page":"233","article-title":"Isolation and characterization of membranes and cell organelles","author":"Evans","year":"1992","journal-title":"Prep. Centr. a Pract. Approach"},{"key":"10.1016\/j.biopha.2025.118922_bib27","doi-asserted-by":"crossref","unstructured":"Graham, J.M. and D. Rickwood, Subcellular fractionation: a practical approach. Vol. 173. 1997: IRL press.","DOI":"10.1093\/oso\/9780199634958.001.0001"},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib28","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1100\/tsw.2002.840","article-title":"OptiPrep\u2122 density gradient solutions for mammalian organelles","volume":"2","author":"Graham","year":"2002","journal-title":"Sci. World J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib29","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1100\/tsw.2002.849","article-title":"Homogenization of mammalian tissues","volume":"2","author":"Graham","year":"2002","journal-title":"Sci. World J."},{"key":"10.1016\/j.biopha.2025.118922_bib30","series-title":"in Biomembrane Protocols: I. Isolation and Analysis.","first-page":"1","article-title":"The identification of subcellular fractions from mammalian cells","author":"Graham","year":"1993"},{"key":"10.1016\/j.biopha.2025.118922_bib31","series-title":"Receptor-ligand Interactions: A Practical Approach: edited by EC Hulme, IRL Press, 1992.\u00a3 25.00 (viii+ 458 pages) ISBN 0 19 963090 7","author":"Davenport","year":"1992"},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib32","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1100\/tsw.2002.851","article-title":"Preparation of crude subcellular fractions by differential centrifugation","volume":"2","author":"Graham","year":"2002","journal-title":"Sci. World J."},{"issue":"19","key":"10.1016\/j.biopha.2025.118922_bib33","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/cmdc.201700369","article-title":"Simultaneous multiple MS binding assays addressing D1 and D2 dopamine receptors","volume":"12","author":"Schuller","year":"2017","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.biopha.2025.118922_bib34","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1476-5381.2009.00604.x","article-title":"Ligand binding assays at equilibrium: validation and interpretation","volume":"161","author":"Hulme","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118922_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2005.10.002","article-title":"Receptor\u2013ligand binding assays: technologies and applications","volume":"829","author":"De Jong","year":"2005","journal-title":"J. Chromatogr. B"},{"issue":"3","key":"10.1016\/j.biopha.2025.118922_bib36","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1523\/JNEUROSCI.07-03-00894.1987","article-title":"Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes","volume":"7","author":"Heuring","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118922_bib37","series-title":"The Serotonin Receptors","author":"Sanders-Bush","year":"2012"},{"issue":"22","key":"10.1016\/j.biopha.2025.118922_bib38","doi-asserted-by":"crossref","first-page":"10815","DOI":"10.3390\/ijms262210815","article-title":"Measuring serotonin binding to its receptors in vitro via charge transfer to ANAP","volume":"26","author":"Brado","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118922_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113612","article-title":"Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response","volume":"154","author":"Erkizia-Santamar\u00eda","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.biopha.2025.118922_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203137","article-title":"Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction","volume":"13","author":"Felsing","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118922_bib41","series-title":"Methods and Protocols","first-page":"107","article-title":"Monitoring G protein-coupled receptor activation using the protein fragment complementation technique split TEV","author":"Wehr","year":"2015"},{"key":"10.1016\/j.biopha.2025.118922_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113870","article-title":"Functional characterization of 5-HT1A and 5-HT1B serotonin receptor signaling through G-protein-activated inwardly rectifying K+ channels in a fluorescence-based membrane potential assay","volume":"175","author":"Gadgaard","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118922_bib43","doi-asserted-by":"crossref","first-page":"1101290","DOI":"10.3389\/fphar.2023.1101290","article-title":"Binding and functional structure-activity similarities of 4-substituted 2, 5-dimethoxyphenyl isopropylamine analogues at 5-HT2A and 5-HT2B serotonin receptors","volume":"14","author":"Hemanth","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118922_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.62.4.25","article-title":"Coadministration with carbidopa enhances the antimyopic effects of levodopa in chickens","volume":"62","author":"Thomson","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118922_bib45","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1167\/iovs.12-9943","article-title":"Muscarinic antagonist control of myopia: evidence for M4 and M1 receptor-based pathways in the inhibition of experimentally-induced axial myopia in the tree shrew","volume":"53","author":"Arumugam","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118922_bib46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0014-4835(87)80037-4","article-title":"Serotonin-accumulating cells in the iris\u2014ciliary body and cornea of various species","volume":"44","author":"Osborne","year":"1987","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0005-2736(84)90457-7","article-title":"Cellular mode of serotonin action on CI\u2212 transport in the rabbit corneal epithelium","volume":"778","author":"Marshall","year":"1984","journal-title":"Biochim. Et. Biophys. Acta (BBA)Biomembr."},{"issue":"2","key":"10.1016\/j.biopha.2025.118922_bib48","first-page":"181","article-title":"Neural serotonin stimulates chloride transport in the rabbit corneal epithelium","volume":"23","author":"Klyce","year":"1982","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0304-3940(83)90519-0","article-title":"The occurrence of serotonergic nerves in the bovine cornea","volume":"35","author":"Osborne","year":"1983","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0420.2005.00551.x","article-title":"Monoamine receptors in human corneal epithelium and endothelium","volume":"84","author":"Grueb","year":"2006","journal-title":"Acta Ophthalmol. Scand."},{"issue":"3","key":"10.1016\/j.biopha.2025.118922_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117581","article-title":"Discovery of molecular markers to discriminate corneal endothelial cells in the human body","volume":"10","author":"Yoshihara","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118922_bib52","first-page":"2143","article-title":"Serotonin levels in aqueous humor of patients with primary open-angle glaucoma","volume":"14","author":"Zanon-Moreno","year":"2008","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.biopha.2025.118922_bib53","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000027268","article-title":"Evaluation of serotonin levels in human aqueous humor","volume":"212","author":"Veglio","year":"1998","journal-title":"Ophthalmologica"},{"issue":"9","key":"10.1016\/j.biopha.2025.118922_bib54","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0161-6420(88)33025-3","article-title":"Serotonin in human aqueous humor","volume":"95","author":"Martin","year":"1988","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.biopha.2025.118922_bib55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1076\/ceyr.23.2.120.5477","article-title":"Effects of serotonergic compounds on aqueous humor dynamics in monkeys","volume":"23","author":"Gabelt","year":"2001","journal-title":"Curr. Eye Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118922_bib56","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/archopht.1989.01070010502011","article-title":"Serotonin, vasoconstrictor of human aqueous humor","volume":"107","author":"Martin","year":"1989","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118922_bib57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157015908787386104","article-title":"Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure","volume":"6","author":"Costagliola","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2025.118922_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.55782\/ane-1994-1053","article-title":"Serotonin and melatonin in the iris\/ciliary processes and their involvement in intraocular pressure","volume":"54","author":"Osborne","year":"1994","journal-title":"Acta Neurobiol. Exp."},{"issue":"10","key":"10.1016\/j.biopha.2025.118922_bib59","first-page":"3035","article-title":"Topical application of serotonin or the 5-HT1-agonist 5-CT intraocular pressure in rabbits","volume":"34","author":"Meyer-Bothling","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118922_bib60","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/jop.1987.3.279","article-title":"Effect of serotonin and its antagonist (ketanserin) on intraocular pressure in the rabbit","volume":"3","author":"Krootila","year":"1987","journal-title":"J. Ocul. Pharm."},{"key":"10.1016\/j.biopha.2025.118922_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biochi.2018.11.006","article-title":"Serotonin in retina","volume":"161","author":"Masson","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2025.118922_bib62","first-page":"1","article-title":"Functional anatomy of the neural retina. Albert & Jakobiec\u2019s principles and practice of ophthalmology","volume":"2","author":"Marc","year":"2008"},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2009.06270.x","article-title":"Serotonin released from amacrine neurons is scavenged and degraded in bipolar neurons in the retina","volume":"111","author":"Ghai","year":"2009","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118922_bib64","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0306-4522(90)90342-2","article-title":"Synaptic organization of serotonin-like immunoreactive amacrine cells in the larval tiger salamander retina","volume":"35","author":"Watt","year":"1990","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.biopha.2025.118922_bib65","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1523\/JNEUROSCI.08-09-03427.1988","article-title":"Serotonergic and serotonin-accumulating neurons in the goldfish retina","volume":"8","author":"Marc","year":"1988","journal-title":"J. Neurosci."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118922_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0006-8993(88)91463-1","article-title":"Putative serotonergic bipolar and amacrine cells in the chicken retina","volume":"439","author":"Millar","year":"1988","journal-title":"Brain Res."},{"issue":"4762","key":"10.1016\/j.biopha.2025.118922_bib67","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1126\/science.3726538","article-title":"Morphological identification of serotonin-accumulating neurons in the living retina","volume":"233","author":"Vaney","year":"1986","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S0952523800007276","article-title":"Synaptic circuitry of serotonin-synthesizing and serotonin-accumulating amacrine cells in the retina of the cane toad, Bufo marinus","volume":"12","author":"Zhu","year":"1995","journal-title":"Vis. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2025.118922_bib69","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00001721-199711000-00006","article-title":"Effects of serotonin on platelet activation in whole blood","volume":"8","author":"Li","year":"1997","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"3","key":"10.1016\/j.biopha.2025.118922_bib70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0024-3205(93)90671-O","article-title":"5HT2-receptors and serotonin release: their role in human platelet aggregation","volume":"53","author":"Cerrito","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118922_bib71","series-title":"Serotonin","first-page":"91","article-title":"Serotonin in platelets","author":"Maclean","year":"2019"},{"issue":"01","key":"10.1016\/j.biopha.2025.118922_bib72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1160\/TH03-05-0330","article-title":"The influence of selective serotonin reuptake inhibitors on human platelet serotonin","volume":"91","author":"Maurer-Spurej","year":"2004","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.biopha.2025.118922_bib73","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0049-3848(94)90231-3","article-title":"Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes","volume":"75","author":"Malyszko","year":"1994","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118922_bib74","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/srep02795","article-title":"A serotonin-induced N-glycan switch regulates platelet aggregation","volume":"3","author":"Mercado","year":"2013","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2025.118922_bib75","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cvr\/cvp205","article-title":"Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake","volume":"84","author":"Lopez-Vilchez","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.biopha.2025.118922_bib76","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00001721-199912000-00009","article-title":"Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin","volume":"10","author":"Nakamura","year":"1999","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"5","key":"10.1016\/j.biopha.2025.118922_bib77","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.yjmcc.2012.02.004","article-title":"Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin","volume":"52","author":"Ziu","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118922_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167902","article-title":"Effects of constant flickering light on refractive status, 5-HT and 5-HT2A receptor in guinea pigs","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:27:32Z","timestamp":1769034452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":78,"alternative-id":["S0753332225011163"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118922","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of the serotonergic system to myopia and the therapeutic effects of atropine and pirenzepine","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118922"}}